Effect of AYUSH 64 in COVID 19

INTERVENTION: Intervention1: AYUSH 64: AYUSH 64 02 Capsules of 500mg each orally thrice daily for 14 days as add‐on therapy to supportive and symptomatic allopathic treatment for COVID 19 patients Control Intervention1: Control arm: Supportive or symptomatic allopathic treatment as per guideline of study site hospital for COVID 19 patients CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: Ordinal scale for Clinical improvement as per WHO ; Duration on mechanical ventilator ; All cause mortality ; Timepoint: 0 7 14 and 28th day SECONDARY OUTCOME: Duration on oxygen therapyTimepoint: 0 7 14 and 28th day Number of cases reporting any ADR AE ; Timepoint: 0 7 14 and 28th day Number of patients developed symptomsTimepoint: 0 14 and 28th day Number of patients who needed mechanical ventilatorTimepoint: 0 14 and 28th day Number of patients who needed oxygen therapyTimepoint: 0 14 and 28th day Total duration of symptomatic phaseTimepoint: 0 14 and 28th day INCLUSION CRITERIA: Asymptomatic or minimal symptomatic COVID 19 patients Patients having 0 to 4 score as per the WHO ordinal scale for clinical improvement Age 18 to 70years Patients who can take oral medicine Patients who are ready to give written consent